Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 27:12:1756287220929486.
doi: 10.1177/1756287220929486. eCollection 2020 Jan-Dec.

Modern best practice in the management of benign prostatic hyperplasia in the elderly

Eric Bortnick  1 , Conner Brown  2 , Vannita Simma-Chiang  2 , Steven A Kaplan  2
Affiliations
Review

Modern best practice in the management of benign prostatic hyperplasia in the elderly

Eric Bortnick et al. Ther Adv Urol. .

Abstract

Benign prostatic hyperplasia (BPH), with its associated lower urinary tract symptoms (LUTS), can be a debilitating disease in the elderly male. Transurethral resection of the prostate (TURP) remains the gold standard; however, many patients will choose to avoid surgery if possible. Medical therapy is an effective alternative, however, new studies are showing that there may be more side effects than previously realized in the elderly male. Newer, novel minimally invasive techniques, including UroLift® and Rezūm™, are gaining favor as alternative office-based procedural techniques that do not require general anesthesia and may better preserve ejaculatory function. Though promising, at this point, these techniques are not approved for all patients. With a range of medical, procedural, and surgical options for treatment of BPH with LUTS, it is important to have a discussion with your patient regarding the short- and long-term risks and benefits, as well as alternatives, before deciding on a treatment plan for your patient with BPH.

Keywords: ambulatory procedures; benign prostatic hyperplasia; elderly; medical therapy; surgery.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: The authors declare that there is no conflict of interest.

References

    1. Uptodate.com. Epidemiology and pathogenesis of benign prostatic hyperplasia, https://www.uptodate.com/contents/epidemiology-and-pathogenesis-of-benig... (accessed 10 July 2020).
    1. Litman HJ, Mckinlay JB. The future magnitude of urological symptoms in the USA: projections using the Boston area community health survey. BJU Int 2007; 100: 820–825. - PubMed
    1. Lee AJ, Garraway WM, Simpson RJ, et al. The natural history of untreated lower urinary tract symptoms in middle-aged and elderly men over a period of five years. Eur Urol 1998; 34: 325–332. - PubMed
    1. Duan Y, Grady JJ, Albertsen PC, et al. Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia. Pharmacoepidemiol Drug Saf 2018; 27: 340–348. - PubMed
    1. Tae BS, Jeon BJ, Choi H, et al. A-blocker and risk of dementia in patients with benign prostatic hyperplasia: a nationwide population based study using the national health insurance service database. J Urol 2019; 202: 362–368. - PubMed

LinkOut - more resources